VALIC Company International Equities Index Fund (VCIEX)
8.83
+0.05
(+0.57%)
USD |
May 15 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.43% | 1.652B | 2.85% | 6.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -380.37M | 9.06% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital growth through investments in equity securities that, as a group, are expected to provide investment results closely corresponding to the performance of the MSCI EAFE Index, which measures the stock performance of large- and mid-cap companies in developed countries outside United States. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | AIG |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
92
-1.382B
Peer Group Low
1.012B
Peer Group High
1 Year
% Rank:
86
-380.37M
-4.690B
Peer Group Low
5.073B
Peer Group High
3 Months
% Rank:
84
-5.843B
Peer Group Low
5.190B
Peer Group High
3 Years
% Rank:
78
-8.323B
Peer Group Low
10.68B
Peer Group High
6 Months
% Rank:
92
-6.020B
Peer Group Low
5.163B
Peer Group High
5 Years
% Rank:
67
-15.58B
Peer Group Low
24.49B
Peer Group High
YTD
% Rank:
87
-5.878B
Peer Group Low
5.176B
Peer Group High
10 Years
% Rank:
56
-28.47B
Peer Group Low
36.30B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 16, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.94% |
| Stock | 98.52% |
| Bond | 0.16% |
| Convertible | 0.00% |
| Preferred | 0.32% |
| Other | 0.06% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| SAP SE | 1.61% | 297.35 | 0.63% |
| Nestle SA | 1.54% | 102.42 | -1.56% |
| ASML Holding NV | 1.51% | 751.20 | -0.83% |
| Roche Holding AG | 1.34% | 310.97 | 0.35% |
| AstraZeneca PLC | 1.32% | 134.46 | -1.05% |
| Novo Nordisk AS | 1.30% | 63.29 | -3.45% |
| Shell PLC | 1.29% | 34.48 | 6.52% |
| Novartis AG | 1.27% | 106.50 | 0.00% |
| HSBC Holdings PLC | 1.18% | 11.75 | 0.00% |
| Siemens AG | 1.01% | 247.50 | 1.94% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.27% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product |
|
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 0.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital growth through investments in equity securities that, as a group, are expected to provide investment results closely corresponding to the performance of the MSCI EAFE Index, which measures the stock performance of large- and mid-cap companies in developed countries outside United States. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | AIG |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-15-25) | 3.53% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 22.75 |
| Weighted Average Price to Sales Ratio | 3.646 |
| Weighted Average Price to Book Ratio | 3.930 |
| Weighted Median ROE | 16.65% |
| Weighted Median ROA | 5.94% |
| ROI (TTM) | 10.94% |
| Return on Investment (TTM) | 10.94% |
| Earning Yield | 0.0623 |
| LT Debt / Shareholders Equity | 0.7353 |
As of March 31, 2025
Growth Metrics
| EPS Growth (1Y) | 14.21% |
| EPS Growth (3Y) | 12.53% |
| EPS Growth (5Y) | 10.12% |
| Sales Growth (1Y) | 5.46% |
| Sales Growth (3Y) | 8.68% |
| Sales Growth (5Y) | 6.21% |
| Sales per Share Growth (1Y) | 7.36% |
| Sales per Share Growth (3Y) | 9.65% |
| Operating Cash Flow - Growth Ratge (3Y) | 8.21% |
As of March 31, 2025
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | 5/31/2024 |
| Last Prospectus Date | 10/1/2024 |
| Attributes | |
| Index Fund |
|
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:VCIEX", "name") |
| Broad Asset Class: =YCI("M:VCIEX", "broad_asset_class") |
| Broad Category: =YCI("M:VCIEX", "broad_category_group") |
| Prospectus Objective: =YCI("M:VCIEX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |